GlassScriptPhysician profile
Fahd Chaudhry
NPI 1407049539
$5,931.05
in general payments reported to CMS, 2019-2025
29 companies · $692 in 2025
The $692 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $194 · 2021: $511 · 2022: $233 · 2023: $318 · 2024: $3,169 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,254 · Travel and Lodging: $1,906 · Education: $18.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,254.45 |
| Travel and Lodging | $1,906.28 |
| Education | $18.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,576.06 | 2021-2024 | Xact, Mini Trek |
| Novartis Pharmaceuticals Corporation | $775.78 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $547.01 | 2019-2025 | Lifevest |
| Atricure, INC. | $332.74 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $277.06 | 2019-2024 | Camzyos, Eliquis |
| Penumbra, INC. | $260.73 | 2022-2025 | Indigo System |
| Janssen Pharmaceuticals, INC | $157.80 | 2019-2023 | Xarelto |
| Abiomed | $145.72 | 2019 | |
| Cardiovascular Systems INC. | $128.96 | 2019-2022 | |
| Amgen INC. | $106.24 | 2019-2022 | |
| Inari Medical, INC. | $99.54 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $96.43 | 2019-2024 | |
| Pfizer INC. | $78.86 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $53.78 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $34.42 | 2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $29.50 | 2025 | Zilver Ptx |
| Shockwave Medical, INC | $26.35 | 2025 | |
| Irhythm Technologies, INC. | $23.03 | 2019 | |
| Preventice Services, LLC | $22.93 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $19.24 | 2019 | |
| Daiichi Sankyo INC. | $18.46 | 2023 | Injectafer |
| Sanofi-Aventis U.S. LLC | $17.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.87 | 2019 | |
| Medtronic Vascular, INC. | $16.27 | 2019 | |
| Angiodynamics, INC. | $15.12 | 2023 | Alphavac |
| Esperion Therapeutics, INC. | $14.54 | 2021 | |
| Novo Nordisk INC | $13.97 | 2024 | Ozempic |
| Lundbeck LLC | $13.51 | 2019 | |
| Glaxosmithkline, LLC. | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fahd Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.